日科化学(300214) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥606,662,875.55, representing a 4.03% increase compared to ¥583,133,877.71 in the same period last year[5]. - The net profit attributable to shareholders was a loss of ¥8,713,724.13, a decline of 149.15% from a profit of ¥17,727,842.35 in the previous year[5]. - Total operating revenue for Q1 2024 was CNY 606,662,875.55, an increase of 4.4% compared to CNY 583,133,877.71 in the same period last year[25]. - Net loss for Q1 2024 was CNY 8,255,402.63, compared to a net profit of CNY 17,691,459.90 in Q1 2023, representing a significant decline[26]. - Basic and diluted earnings per share for Q1 2024 were both CNY -0.01, compared to CNY 0.04 in Q1 2023[26]. Cash Flow - The net cash flow from operating activities was -¥121,522,266.60, a decrease of 359.05% compared to ¥46,909,900.09 in the same period last year[5]. - The company's cash inflow from operating activities was CNY 511,584,934.48, down from CNY 560,953,053.94 in the previous year[28]. - Total cash outflow from operating activities amounted to 633,107,201.08 CNY, up from 514,043,153.85 CNY year-over-year[29]. - The net cash flow from investment activities was -182,786,599.19 CNY, worsening from -113,453,896.17 CNY year-over-year[29]. - The net cash flow from financing activities increased to 298,188,517.11 CNY, up from 54,326,467.00 CNY year-over-year[29]. Assets and Liabilities - Total assets increased by 11.48% to ¥4,394,040,393.49 from ¥3,941,543,089.22 at the end of the previous year[5]. - Total liabilities rose to CNY 1,821,851,067.24, compared to CNY 1,362,638,446.26 in the same period last year[24]. - The company's equity attributable to shareholders was CNY 2,545,727,108.15, a slight decrease from CNY 2,579,300,746.36 in Q1 2023[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 13,697[17]. - The largest shareholder, Zhao Dongri, holds 17.55% of shares, totaling 81,785,037 shares[17]. - The second-largest shareholder, Tai'an Lumin Investment, holds 13.32% of shares, totaling 62,067,859 shares[17]. Inventory and Expenses - The company’s inventory increased by 34.78% to ¥299,754,425.13, as it prepared materials for ongoing projects[10]. - Research and development expenses decreased by 40.35% to ¥6,763,408.41 from ¥11,338,619.86, reflecting a reduction in project investments[12]. - Total operating costs for Q1 2024 were CNY 611,694,418.46, up 8.2% from CNY 565,528,263.62 in Q1 2023[25]. - The company reported a significant increase in financial expenses, amounting to ¥1,681,134.88, primarily due to higher interest costs[12]. Other Financial Metrics - The weighted average return on equity was -0.34%, down from 0.70% in the previous year, indicating a decline in profitability[5]. - The company reported a significant increase in short-term borrowings, rising by 87.85% to ¥405,855,564.48 from ¥216,050,744.25[10]. - The company's cash and cash equivalents at the end of the period amount to ¥86,364,350.22, a decrease from ¥88,770,623.82 at the beginning of the period[22]. - The company has ongoing projects in construction with a total value of ¥1,743,435,363.11, up from ¥1,529,539,784.40[22]. Audit Status - The first quarter report was not audited[30].